医疗器械公司Globus Medical Inc.(纽约证券交易所代码:GMED)周一(11月5日)盘后股价大涨9.55%,主要得益于公布的第三季度业绩和全年展望超出市场预期。
财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。
公司称,第三季度业绩出色主要得益于收购NuVasive公司,以及旗下脊柱产品销售和使能技术产品及服务销量的大幅增长。报告期内,美国市场净销售额同比增长60.3%,国际市场净销售额更是跃升74.8%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.